Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes
- 1 February 2002
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 282 (2) , F352-F357
- https://doi.org/10.1152/ajprenal.00160.2001
Abstract
Ischemia-reperfusion injury (IRI) is a complex and incompletely understood process involving a cascade of events that culminates in apoptotic and/or necrotic cell death. Natural IgM antibodies and complement have been implicated in the pathogenesis of IRI in a variety of organ systems as have T lymphocytes in renal IRI. To investigate the role of Ig and T lymphocytes in renal IRI, recombination-activating gene (RAG)-1-deficient mice were studied. RAG-1(−/−) mice were not protected from acute renal failure induced by 27.5 min of bilateral renal ischemia and subsequent reperfusion [serum urea nitrogen levels 30 h after reperfusion, 155.2 ± 5.6 and 152.8 ± 11.4 mg/dl in RAG-1(−/−) and wild-type mice, respectively;n = 13 each]. Histological examination showed acute tubular necrosis and neutrophilic infiltration with no significant differences between groups. In contrast with other organ systems, Igs were not found in kidneys at time points ranging from 1 min to 30 h after ischemia. Thus Igs and mature T lymphocytes do not appear to play a significant role in the pathogenesis of IRI in the kidney.Keywords
This publication has 37 references indexed in Scilit:
- Predominant role for C5b-9 in renal ischemia/reperfusion injuryJournal of Clinical Investigation, 2000
- Complement Activation after Oxidative StressThe American Journal of Pathology, 2000
- Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.The Journal of Experimental Medicine, 1996
- Antibodies to ICAM-1 Protect Kidneys in Severe Ischemic Reperfusion InjuryBiochemical and Biophysical Research Communications, 1995
- REGULATION OF THE COMPLEMENT CASCADE BY SOLUBLE COMPLEMENT RECEPTOR TYPE 1Transplantation, 1995
- Alternative pathway activation of complement by cultured human proximal tubular epithelial cellsKidney International, 1994
- Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and NecrosisScience, 1990
- RAG-1 and RAG-2, Adjacent Genes That Synergistically Activate V(D)J RecombinationScience, 1990
- The V(D)J recombination activating gene, RAG-1Cell, 1989
- Lung injury mediated by antibodies to endothelium. I. In the rabbit a repeated interaction of heterologous anti-angiotensin-converting enzyme antibodies with alveolar endothelium results in resistance to immune injury through antigenic modulation.The Journal of Experimental Medicine, 1983